EI ENDOCYTE INC Stock: price and directors' dealings · United States · SEC (Form 4)Track the ENDOCYTE INC stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). The latest transaction was reported on 8 February 2016 (Attribution). Among the most active insiders: Brinkley Michael A.. All data is free.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 8 February 2016
All Executives24 Thresholds0 Prospectus0 Other0
Declarations 24 total
◆ Chief Medical Officer · Executives · 4 Feb 2016
10,000 shares Common Stock SEC:0001144204-16-079686:0
◆ VP OF QUALITY · Executives · 4 Feb 2016
5,000 shares Common Stock SEC:0001144204-16-079687:0
● VP OF QUALITY · Executives · 4 Feb 2016
618 shares Common Stock SEC:0001144204-16-079687:1
● VP OF QUALITY · Executives · 6 Feb 2016
580 shares Common Stock SEC:0001144204-16-079687:2
◆ VP of CLINICAL OPERATIONS · Executives · 4 Feb 2016
8,750 shares Common Stock SEC:0001144204-16-079689:0
● VP of CLINICAL OPERATIONS · Executives · 4 Feb 2016
1,078 shares Common Stock SEC:0001144204-16-079689:1
● VP of CLINICAL OPERATIONS · Executives · 6 Feb 2016
694 shares Common Stock SEC:0001144204-16-079689:2
◆ Vice President of Research · Executives · 4 Feb 2016
8,750 shares Common Stock SEC:0001144204-16-079690:0
● Vice President of Research · Executives · 4 Feb 2016
1,081 shares Common Stock SEC:0001144204-16-079690:1
● Vice President of Research · Executives · 6 Feb 2016
695 shares Common Stock SEC:0001144204-16-079690:2
◆ Chief Science Officer · Executives · 4 Feb 2016
8,750 shares Common Stock SEC:0001144204-16-079691:0
● Chief Science Officer · Executives · 4 Feb 2016
1,081 shares Common Stock SEC:0001144204-16-079691:1
● Chief Science Officer · Executives · 6 Feb 2016
695 shares Common Stock SEC:0001144204-16-079691:2
◆ COO and CFO · Executives · 4 Feb 2016
14,375 shares Common Stock SEC:0001144204-16-079692:0
● COO and CFO · Executives · 4 Feb 2016
1,771 shares Common Stock SEC:0001144204-16-079692:1
● COO and CFO · Executives · 6 Feb 2016
694 shares Common Stock SEC:0001144204-16-079692:2
● Corporate Controller · Executives · 6 Feb 2016
525 shares Common Stock SEC:0001144204-16-079693:1
◆ VP of Human Resources · Executives · 4 Feb 2016
6,250 shares Common Stock SEC:0001144204-16-079694:0
◆ President and CEO · Executives · 4 Feb 2016
26,875 shares Common Stock SEC:0001144204-16-079688:0
● President and CEO · Executives · 4 Feb 2016
3,320 shares Common Stock SEC:0001144204-16-079688:1
● President and CEO · Executives · 6 Feb 2016
2,085 shares Common Stock SEC:0001144204-16-079688:2
◆ Corporate Controller · Executives · 4 Feb 2016
3,750 shares Common Stock SEC:0001144204-16-079693:0
▲ Director · Executives · 15 Jan 2016
20,000 shares Common Stock SEC:0001144204-16-076291:0
Canonical exit: 14 Apr 2016 (T+90) ▲ Director · Executives · 19 Jan 2016
10,000 shares Common Stock SEC:0001144204-16-076291:1
Canonical exit: 18 Apr 2016 (T+90) About ENDOCYTE INC ENDOCYTE INC is a company focused on developing targeted therapies for cancer treatment. It is listed on the XNAS market.